| dc.contributor.author | Mukhopadhyay, Debasmita | |
| dc.contributor.author | AlSawaftah, Nour Majdi | |
| dc.contributor.author | Husseini, Ghaleb | |
| dc.date.accessioned | 2021-05-24T07:03:52Z | |
| dc.date.available | 2021-05-24T07:03:52Z | |
| dc.date.issued | 2021 | |
| dc.identifier.citation | Mukhopadhyay, D., AlSawaftah, N., & Husseini, G. A. (2020). Identification of Novel MicroRNAs as Promising Therapeutics for SARS-CoV-2 by Regulating the EGFR-ADAM17 Axis: An In Silico Analysis. ACS Pharmacology & Translational Science, 4(1), 396–399. https://doi.org/10.1021/acsptsci.0c00199 | en_US |
| dc.identifier.issn | 2575-9108 | |
| dc.identifier.uri | http://hdl.handle.net/11073/21486 | |
| dc.description.abstract | Cancer patients contracting SARS-CoV-2 encounter additional challenges due to inflammatory bursts and lymphopenia, which may aggravate breast cancer prognosis. In this in-silico analysis, we identified the potential of miRNAs as new therapeutic targets to treat breast cancer patients infected with COVID-19 via the regulation of ADAM17 and EGFR expression microRNAs. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | American Chemical Society | en_US |
| dc.relation.uri | https://doi.org/10.1021/acsptsci.0c00199 | en_US |
| dc.subject | SARS-CoV-2 | en_US |
| dc.subject | MicroRNA | en_US |
| dc.subject | ADAM17 | en_US |
| dc.subject | Epidermal growth factor receptor (EGFR) | en_US |
| dc.subject | Breast cancer | en_US |
| dc.title | Identification of Novel MicroRNAs as Promising Therapeutics for SARS-CoV-2 by Regulating the EGFR-ADAM17 Axis: An In Silico Analysis | en_US |
| dc.type | Peer-Reviewed | en_US |
| dc.type | Article | en_US |
| dc.type | Preprint | en_US |
| dc.identifier.doi | 10.1021/acsptsci.0c00199 | |
